Mucosa Tablet
FDA Label NDC 49483-272

14 label sections · Submitted to the FDA by Time Cap Laboratories,inc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Time Cap Laboratories,inc for the product Mucosa (NDC 49483-272). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - ask doctor, otc - when using, otc - stop use, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Active Ingredient

Active ingredient (in each immediate-release tablet)

Guaifenesin 400 mg

Otc - Purpose

Purpose

Expectorant

Indications & Usage

Uses

  • helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive to rid the bronchial passageway of bothersome mucus

Warnings

Warnings

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Dosage & Administration

Directions

  • adults and children 12 years of age and older: take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 doses in 24 hours.
  • children under 12 years of age: do not use

Inactive Ingredient

Inactive ingredients colloidal silicon dioxide, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, silicon dioxide, sodium starch glycolate, stearic acid

Package Label.Principal Display Panel

272r-timely-200s-label (272r Timely 200s Label)

272r-timely-200s-label (272r Timely 200s Label)

Image Description60lable (272rlabel)

Image Description60lable (272rlabel)

* Please review the disclaimer below.